At a glance
- Originator Pfizer
- Class
- Mechanism of Action Farnesyltranstransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 23 Jun 2000 Pfizer has merged with Warner-Lambert
- 12 Aug 1999 New profile
- 12 Aug 1999 Preclinical development for Cancer in USA (Unknown route)